Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

12.74 +0.61 (+5.07%)
Streaming Delayed Price Updated: 11:10 AM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
News headline image
Mind Medicine Stock Is Not a Trip To Take Just Yet ↗
Psychedelic drugs may eventually be a big market. However, investors in MNMD stock may be getting in a little too early. 
Via InvestorPlace
Topics Cannabis Law Enforcement
News headline image
MindMed Collaborates with Nextage Therapeutics for Brain Targeting Liposome System ↗
MindMed (NASDAQ: MNMD) and Israel-listed Nextage Therapeutics have entered into an exclusive collaborative development program to optimize the delivery of... 
Via Benzinga
News headline image
Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research ↗
MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research MindMed (NASDAQ: 
Via Benzinga
News headline image
Cannabis Movers & Shakers: The Parent Company, MindMed, Australis, Flourish Software ↗
The Parent Company Welcomes Desiree Perez To Its Board TPCO Holding Corp. (OTCQX: 
Via Benzinga
Topics Cannabis
News headline image
The Jury’s Still Out on Psychedelics Play MindMed Stock ↗
Selling off after its NASDAQ uplisting, it's hard to tell whether MNMD stock will soar higher following recent positive developments. 
Via InvestorPlace
News headline image
MindMed To Conduct The First Modern Research On Mescaline In Switzerland ↗
MindMed (NASDAQ: MNMD) (NE... 
Via Benzinga
News headline image
Psychedelic Drug Developer Sets Sights On This Age-Old Hallucinogen ↗
MindMed stock fell after it said a Swiss ethics committee cleared it to begin a study on the effects of the hallucinogen mescaline. 
Via Investor's Business Daily
News headline image
22 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Advaxis, Inc. (NASDAQ: ADXS) shares rose 29.6% to $0.6289 in pre-market trading after jumping over 14% on Tuesday. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 16.3%... 
Via Benzinga
News headline image
Strong Cash Balance Should Provide a Foundation for MindMed Stock ↗
Now that it has joined the Nasdaq Exchange, MNMD stock will have its ups and downs but firm financials should instill shareholder confidence. 
Via InvestorPlace
News headline image
MNMD Stock: The Big News That Has MindMed Investors Psyched Today ↗
MindMed (MNMD) stock is getting a boost on Monday following news from the FDA that allows the company to continue development. 
Via InvestorPlace
News headline image
MindMed Stock Moves Higher After Finalizing Generalized Anxiety Disorder As Initial Indication For LSD Trial ↗
After receiving Type C Meeting Responses from the FDA, MindMed (NASDAQ: MNMD) has selected Generalized Anxiety Disorder as an initial indication for its Project Lucy,... 
Via Benzinga
News headline image
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public ↗
Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021. Compass Pa... 
Via Benzinga
News headline image
EXCLUSIVE: MindMed CEO Talks Mission To 'Discover, Develop And Deploy' Psychedelics ↗
Mind Medicine Inc (NASDAQ: MNMD) was started to address mental wellness, CEO and co-founder J.R. Rahn told Benzinga's Global Small Cap Conference Thursday. MindMed... 
Via Benzinga
News headline image
Benzinga Global Small Cap Conference: How Do Investors Pick Winners In The Psychedelics Space? ↗
Simeon Schnapper, a managing partner at JLS Fund, took 30 minutes from his busy schedule to share his insights into what makes a w... 
Via Benzinga
News headline image
Video: Psychedelic Stocks With JLS Fund's Simeon Schnapper & MindMed's JR Rahn ↗
During the Benzinga Global Small-Cap Conference on Thursday morning, psychedelics executives discussed the markets and companies' prospects. 
Via Benzinga
News headline image
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week ↗
Welcome to the Cannabis Countdo... 
Via Benzinga
Topics Cannabis
News headline image
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M ↗
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound... 
Via Benzinga
News headline image
Video: The Psychedelics Market With Entheon Biomedical, MagicMed, Natan Ponieman ↗
Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday’s show, hosts Patrick&... 
Via Benzinga
Topics Cannabis
News headline image
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders ↗
Concentration of ownership in psychedelic drug stocks has reached a new extreme. We explain how and why we don't see this trend as being sustainable. 
Via Talk Markets
News headline image
The Next Psychedelic Stock To Uplist On The Nasdaq? ↗
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next? 
Via Talk Markets
News headline image
When Will The Selling Pressure In These 2 Hot Stocks End? ↗
On April 29, shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) hit a wall of resistance at the $4.30 level. Since then, they have been in a freefall. There’s a good... 
Via Benzinga
News headline image
Mind Medicine Stock Is Soaring After Its NASDAQ Debut. What's Next? ↗
Diversification may be a prudent step. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Precipio (NASDAQ:PRPO) stock moved upwards by 111.42% to $3.85 during Monday's regular session. The current volume of 113.0 million shares is 18552.84% of... 
Via Benzinga
News headline image
Is It Time to Sell These 3 Stocks? ↗
It may be time to sell GameStop Corp. (NYSE: GME), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), and Archer-Daniels-Midland Company (NYSE: ADM) and the reasons why will... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers BioVie (NASDAQ:BIVI) shares increased by 12.96% to $19.78 during Monday's pre-market session. The company's market cap stands at $275.2 million. Ocugen (... 
Via Benzinga
News headline image
Fintech Focus Roundup For May 2, 2021 ↗
Apex Fintech Solutions Announces Blow-Out Earnings Ahead Of NYSE Listing What Happened: Blank-check company Northern Star Investment Corporation II announced that Apex... 
Via Benzinga
News headline image
The 'Boiler Room' Stock Pitch Recap: MindMed, Ford, Generac, Microchip And More ↗
Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO ... 
Via Benzinga
News headline image
MindMed Stock Hits A Wall Of Resistance ↗
Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) have hit a wall of resistance at the $4.30 level. This has put a top on the stock. Resistance is a large concentration of... 
Via Benzinga
MindMed's Nasdaq Listing Enables Institutions Diversified Access To A New Age Of Medicine ↗
Mind Medicine (MindMed) Inc (NASDAQ:MNMD) (NEO: MMED), a l... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.